Anila Lingamneni joined Haemonetics in April 2020 as Executive Vice President, Chief Technology Officer. She oversees the Company’s Innovation Agenda and leads its research, development, software and medical and clinical affairs.
Previously, Ms. Lingamneni was Vice President, Renal R&D at Baxter International, where she was responsible for product portfolio delivering renal therapy solutions to dialysis patients, including devices, software, disposables and fluids. While there, she drove a globally distributed team of engineers and scientists to drive long-term product roadmap definition and therapy innovation and delivered critical launches. Before joining Baxter, Ms. Lingamneni held several roles at General Electric Healthcare, including Chief Technology Officer of the X-Ray Diagnostic Imaging Business Unit, where she led a global engineering function, rebalanced portfolio investments to drive value and managed expansion into emerging markets.
Ms. Lingamneni received a Bachelor of Science in Electrical and Electronics Engineering and a Master of Science in Mathematics from Birla Institute of Technology and Science in India. She also earned a Master of Science in Biomedical Engineering from Iowa State University. Ms. Lingamneni has received numerous awards, including the Healthcare Businesswomen's Association Outstanding Luminary Award and the Society of Women Engineers Women of the Year Award, and has authored numerous publications.